Form D · Pharmaceuticals
Cure Pharmaceutical Holding Corp.
Oxnard, CA · CIK 0001643301
Offering snapshot reported Nov 13, 2020 · SEC filing
- Reported sold
- $11.5M Offering amount: $11.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 30, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 13, 2020 | Initial | $11,500,000 | No comparison | 1 | SEC filing |
| May 29, 2019 | Initial | $19,038,000 | No comparison | 25 | SEC filing |
| May 29, 2019 | Amendment | $19,038,000 | $0vs May 29, 2019 | 25 | SEC filing |
| Apr 5, 2018 | Initial | $1,000,000 | No comparison | 23 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $306K (estimated)
- Form D file number
- 021-380452
For further explanation, please see the Current Report on Form 8-K filed by the Issuer on November 2, 2020.
Placement agent fee. This amount may increase up to an additional $480,000 upon achievement of certain milestones.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Axiom Capital Management, Inc. | 265801 |
Source: Form D, filed Nov 13, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Bell | Director |
| Charles Berman | Director |
| Lauren Chung | Director |
| Robert Davidson | Director, Executive |
| Nancy Duitch | Director |
| Alan Einstein | Director |
| Anya Goldin | Director |
| Josh Held | Director |
| Alex Katz | Executive |
| Ruben King Shaw | Director |
| Edward Maliski | Executive |
| Mike Redard | Executive |
| Jessica Rousset | Executive |
| Gene Salkind | Director |
| Mark Udell | Executive |
| William Yuan | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1620 Beacon Place
Oxnard, CA, 93033
Oxnard, CA, 93033